M. Blake Lockwood, MD

Medical Oncologist

Originally from Stuttgart, Arkansas, Dr. Blake Lockwood completed medical school at the University of Arkansas for Medical Sciences (UAMS) in Little Rock, followed by an Internal Medicine residency and Hematology/Oncology Fellowship, both also at UAMS. Dr. Lockwood was drawn to oncology because of all of the new advances in treatment options and the relationships developed with patients and their families while navigating cancer treatment. 

Dr. Lockwood and his wife, Lindsay, have three children named Matthew, Anna and Meredith. In his spare time, he enjoys spending time with family and is an avid Razorback and St. Louis Cardinals fan.

Medical School: University of Arkansas for Medical Sciences College of Medicine
Internship & Residency: Internal Medicine, UAMS
Fellowship: Hematology/Oncology, UAMS

Highlands

in the News

Our team is dedicated to staying at the forefront of oncology, and we are proud to share their latest advancements and recognition.

Surgeon highlights rising colorectal cancer cases among young adults

As March marks Colorectal Cancer Awareness Month, one doctor says he has seen an increase in cases in young adults.

According to the World Health Organization, colorectal cancer is now ranked as the third most common cancer worldwide and the second leading cause of cancer-related fatalities.

Highlands Oncology receives innovator award

Springdale-based Highlands Oncology, the region’s largest cancer-care provider, recently received a 2025 Association of Cancer Care Centers (ACCC) Innovator Award.

New cancer vaccine trial underway at Highlands Oncology in NW Arkansas

Some are calling it the research of the future — an mRNA vaccine to aid in cancer research.

There's an experimental trial for the vaccine that's been going on for the past year at Highlands Oncology in Springdale.

Simple, free, life-saving; Screening detects lung cancer early

As Joanna Thompson thinks back to the many lung cancer screenings she’s done over the years at Highlands Oncology in Springdale, one patient always springs to mind — the very first one whose screening revealed cancer in its early stages.